sur ADOCIA (EPA:ADOC)
ADOCIA Secures €10 Million Fundraising for Growth
ADOCIA, a biopharmaceutical company, announced a fundraiser raising €10 million in gross proceeds through issuing 1,262,626 new shares with attached warrants. CVI Investments, Inc. subscribed to this offer. Settlement and delivery are anticipated on December 8, 2025.
The raised funds will support ADOCIA’s strategic development, extending its cash runway to early 2027. This includes investing in the industrialization of their BioChaperone® technology and innovating through the AdoXLong™ platform.
Approximately 50% of the funds are designated for the development of the AdoXLong™ platform, with 30% for industrial scale processes, and 20% for working capital. The new shares will be listed on Euronext Paris.
CEO Olivier Soula expressed gratitude to CVI Investments for their support, highlighting the capital increase's role in accelerating company growth.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ADOCIA